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Abstract
Background: The glycaemic response to foods is dependent on the quality and content of
carbohydrates. Carbohydrates in the form of dietary fibre have favourable effects on insulin and
glucose metabolism and may help to control energy intake. Dairy products have a relatively low
carbohydrate content, and most of the carbohydrate is in the form of lactose which causes
gastrointestinal symptoms in part of the population. In order to avoid these symptoms, dairy
products can be replaced with lactose-free dairy products which are on the market in many parts
of the world. However, the effects of lactose-free products on insulin and glucose metabolism have
not been studied.
Methods: In the present study, we investigated the effects of 1) a lactose-free milk drink, 2) a novel
fibre-enriched, fat- and lactose-free milk drink and 3) normal fat-free milk on serum glucose and
insulin levels and satiety using a randomized block design. Following an overnight fast, 26 healthy
volunteers ingested 200 ml of one of these drinks on three non-consecutive days. Insulin and
glucose levels and subjective satiety ratings were measured before the ingestion of the milk product
and 20, 40, 60, 120 and 180 minutes after ingestion. The responses were calculated as the area
under the curve subtracted by the baseline value (AUC minus baseline).
Results: The insulin response was significantly lower for the fibre-enriched milk drink than it was
for the other milk products (AUC, P = 0.007). There were no differences in the response for
glucose or in the AUC for the subjective satiety ratings between the studied milk products.
Conclusion: The present results suggest that this novel milk drink could have positive effects on
insulin response.
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Background
A combination of metabolic disturbances, including cen-
tral obesity, cardiovascular disease, dyslipidaemia, insulin
resistance and elevated blood pressure, affects the life of a
quarter of the world's adult population [1]. Continuous
imbalance in the above-mentioned metabolic conditions,
in association with obesity, leads to an increased risk of
developing type 2 diabetes and related metabolic co-mor-
bidities. Recent studies have shown that lifestyle changes
have promising effects on the prevention of type 2 diabe-
tes [2-6]. Weight loss by dietary modification and
increased physical activity is the primary recommenda-
tion also in the treatment of the metabolic syndrome
[7,8]. Generally, maintaining a balance between energy
intake and expenditure has proven difficult for people
struggling with overweight. The composition of the diet
and the satiating effects of foods have emerged as an
important research area in the field of overweight and glu-
cose and insulin metabolism.
An inverse association between the consumption of dairy
products and BMI has been detected in several study pop-
ulations [9-12], and the increased intake of dairy products
has been shown to decrease weight gain [13]. The effect of
dairy products on weight loss remains a controversial area
of research [14]. Epidemiological studies have indicated
that an increased intake of calcium and dairy products
may be associated with a lower prevalence of the meta-
bolic syndrome and type 2 diabetes [15-18]. Thus, dairy
products could be considered as a component of diets
aiming at optimal weight management.
The prevalence of lactose-intolerance differs among Euro-
pean populations, ranging from 4% (Denmark) to 50%
(average prevalence in Italy) [19]. Gastrointestinal symp-
toms may reduce the intake of dairy products and people
who are not able to consume dairy products may be at risk
for inadequate calcium and vitamin D intake[9]. Lactose-
free products are critical for assuring adequate calcium
and vitamin D intake in lactose-intolerant people. In the
digestive process, the lactose-molecule is split into two
monosaccharides, glucose and galactose, which may have
independent effects on insulin metabolism. This should
be taken into consideration when potential consumers
include people with overweight, insulin resistance and
lactose-intolerance. To our knowledge, the insulin
responses of lactose-free dairy products have not been pre-
viously studied. Moreover, the effects of a lactose-free
milk drink on glucose metabolism are not known.
The glycaemic response to particular foods depends on
several variables, including the structure of the carbohy-
drate, the fibre content and the preparation or processing
of the food in question [20]. Foods with a low-glycaemic
response have been shown to exert beneficial effects on
blood glucose and insulin levels [21,22], on the incidence
of type 2 diabetes [23,24] and on prolonged satiety [25].
Therefore, it is possible that low-glycaemic foods contrib-
ute to preventing the development of metabolic disorders,
such as insulin resistance, dyslipidaemia and cardiovascu-
lar diseases [26,27]. However, the current data are incon-
sistent [28].
Increasing fibre and whole grain intake affects glucose and
insulin metabolism favourably and may enhance insulin
sensitivity in obese subjects and in subjects with impaired
glucose tolerance [29-33]. Among other functions, fibre
enhances satiation and satiety due to its viscosity-produc-
ing and bulking effects [34] and it may promote weight
reduction in obese subjects [35]. The effects of natural,
added, soluble and insoluble fibres on weight reduction
have been found to be fairly similar [35]. Adding soluble
fibre in fat-free dairy products could enhance the prod-
ucts' positive effects on weight management and balance
the otherwise high insulin response of dairy products.
The aim of the present study was to compare the acute
effects of a lactose-free milk drink, a novel milk drink
(fibre-enriched, fat- and lactose-free) and regular fat-free
milk on fasting insulin and glucose levels and on subjec-
tive satiety levels in healthy subjects.
Methods
Subjects
Thirty-three subjects were recruited by an advertisement
in a local newspaper. Healthy men and women within the
age range of 18-65 years, with normal and regular eating
habits and a body mass index (BMI) of 20-30 kg/m2 were
eligible for the study. Subjects who were diabetic or had a
fasting serum glucose level of 6.2 mmol/l or more, had
milk protein allergy or lactose intolerance, were pregnant
or lactating or took medication for chronic digestive dis-
orders, or were participating in another study, were not
eligible for the present study. Two subjects were excluded
because of their medical history and five discontinued the
study for personal reasons. Twenty-six healthy subjects
(16 female and 10 males completed the study. The sub-
jects' mean age was 48 ± 11 years (age range 25-64) and
their mean BMI was 24.6 ± 2.9 kg/m2 (BMI range 20-30).
Study protocol
A randomized response profile block design study was
conducted to investigate the effect of different milk prod-
ucts on serum glucose levels, insulin levels and satiety.
Prior to the intervention, all enrolled subjects underwent
an interview and their lifestyle habits (medical history,
smoking, alcohol use and physical activity) were assessed.
The subjects' waist and hip circumference and height and
body weight without shoes and outdoor clothing were
measured, and their BMI was calculated using the stand-Nutrition Journal 2009, 8:45 http://www.nutritionj.com/content/8/1/45
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ard equation (kg/m2). Furthermore, cholesterol (enzy-
matically), triglyceride (enzymatically) and glucose
concentrations were measured to assess baseline values.
The intervention comprised three study days. The subjects
were advised to avoid exhausting exercise in the evening
before a study day. After a 12-hour overnight fast, a
venous blood sample was collected and the subjects con-
sumed the study product in 20 minutes. Additional blood
samples were taken 20, 40, 60, 120 and 180 minutes after
the fasting blood sample. The subjective satiety level was
measured immediately after each sampling. After 180
minutes, the subjects were allowed to eat freely, but they
were instructed to keep a record of everything they ate dur-
ing the rest of the day in a food diary. The subjects gave
their written informed consent before entering the study.
The study protocol was approved by the Ethics Committee
of the Hospital District of Helsinki and Uusimaa.
Study products
The studied milk products comprised fat-free milk, a fat-
and lactose-free milk drink and a very low-energy poly-
dextrose and calcium-enriched fat- and lactose-free milk
drink (fibre-enriched milk drink) (Valio ProFeel®, Valio
Ltd, Helsinki, Finland). The subjects consumed 200 ml of
one of these products on three non-consecutive study
days. The energy and nutrient contents of the milk prod-
ucts are shown in Table 1. As illustrated, the fibre-
enriched milk-drink had the highest calcium content (180
mg/100 g). The vitamin D content of all the studied prod-
ucts was 0.5 μg/100 g. The fibre enrichment did not affect
the taste of the milk drink, which was confirmed by a
blinded taste test performed by expert panellists.
Blood measurements
The venous blood samples were taken into gel serum
tubes and centrifuged (10 min at 3000 rpm) within 30
minutes of sampling. The serum was immediately sepa-
rated and frozen in -20°C for further analysis of glucose
and insulin levels. Serum insulin was analysed using
luminoimmunometric techniques and glucose was ana-
lysed using hexokinase techniques at United Laboratories
Ltd, Helsinki, Finland.
Subjective satiety measurements
Subjective satiety was measured by Visual Analogue Scale
(VAS) and Satiety Labeled Intensity Magnitude (SLIM) rat-
ings. The following VAS ratings were used: 'How hungry
do you feel right now?' (hunger), 'How full do you feel
right now?' (fullness), 'How much do you think you could
eat right now?' (prospective food consumption), 'How
strong is your desire to eat right now?' (desire to eat) and
'How satisfying did you find the study product?' (satisfy-
ing satiety effect of the study product) were used. The VAS
consisted of 100 mm horizontal lines with extreme sensa-
tions anchored at the ends of the lines. The subjects com-
pleted the VAS questionnaire by placing a vertical slash on
the line corresponding to their sensation. SLIM consisted
of one question, 'How hungry or full are you right now?',
with a vertical line scale for subjects to mark horizontally
to indicate their potential sensations of fullness and hun-
ger. Subjective satiety rating questionnaires were com-
pleted immediately after each blood sampling.
Food diaries
The subjects completed a food diary on all three study
days. They were advised to mark down, as precisely as pos-
sible, what was consumed during a study day, as well as
the time and place of consumption. The subjects used
grams or decilitres to specify the amount of food con-
sumed and they were supplied with a Portion Size Booklet
(National Public Health Institute, University of Helsinki,
Department of Nutrition, Helsinki 1985) to help them
estimate the amounts and portion sizes. The food diaries
were analysed with Nutrica 3.1 software programme
(KELA, Turku, Finland).
Statistical analyses
The results are presented as means with standard devia-
tions (SD) and 95% confidence intervals (CI). The
responses to insulin and glucose levels and subjective sati-
ety were calculated as the area under the curve subtracted
by the baseline value (AUC minus baseline). The tested
products were compared with ANOVA for repeated meas-
ures. Sidak's adjustment was applied to correct levels of
significance for post hoc pairwise testing. The normality
of variables was evaluated using the Shapiro-Wilk statis-
Table 1: Nutrient composition in 100 g of the studied products.
Fibre-enriched
milk drink
Lactose-free milk drink Fat-free milk
Energy (kJ) 84 110 140
Protein (g) 3.3 3.3 3.3
Carbohydrate (g) 1.8 3.1 4.9
of which lactose (g) 0.0 0.0 4.9
Fibre (g) 1.5 0.0 0.0
Fat (g) 0.0 0.0 0.0
Calcium (mg) 180 120 120Nutrition Journal 2009, 8:45 http://www.nutritionj.com/content/8/1/45
Page 4 of 7
(page number not for citation purposes)
tics. Insulin values under the detection limit 2.0 mU/l
were compensated with value 1.0 mU/l (28%). Statistical
analyses were performed with SPSS 14.0 software (SPSS
Inc., Chicago, Illinois, USA).
Results
Glucose and insulin
There was a statistically significant difference in AUC
minus baseline for insulin between the milk products (P
= 0.007). In a pairwise comparison, serum insulin con-
centration increased significantly less following the con-
sumption of the fibre-enriched milk drink compared to
fat-free milk and the fat-and lactose-free milk drink (2.1
vs. 4.3, P = 0.036 and 2.1 vs. 3.9, P = 0.011, respectively)
(Fig. 1(B)). There were no differences in AUC minus base-
line for glucose between the milk products (P = 0.31). The
glucose curves for milk products are presented in Fig.
1(A).
Satiety and food intake
No significant differences were observed in AUC minus
baseline values for subjective satiety ratings (Table 2). The
fat- and lactose-free milk drink was found to be more sati-
ating than the fibre-enriched milk drink at 20 minutes
after consumption (48.8 vs. 36.1, P = 0.042). Based on the
food diaries, the subjects' energy, protein, total fat, fatty
acid and fibre consumption remained the same through-
out the study and did not differ significantly between the
three study days. Carbohydrate consumption was higher
on the fibre-enriched milk drink study day compared to
the fat-free milk study day (P = 0.03) (Table 3).
Discussion
In this study, we investigated the effects of a lactose-free
milk drink, a novel fibre-enriched lactose- and fat-free
milk drink and regular fat-free milk on glucose and insu-
lin responses and satiety levels in healthy subjects. The
insulin response was markedly lower after the consump-
tion of the fibre-enriched milk-drink compared to the
other products. Although there was no significant differ-
ence in the AUC response of glucose between the study
products, the fibre-enriched milk drink appeared to equal-
ize the glucose response.
The metabolic syndrome is characterized by insulin resist-
ance and hyperinsulinemia, as well as several detrimental
symptoms, such as hypertension, fatty liver disease and
impaired glucose disposal [36]. In addition, continuously
elevated insulin concentrations impair normal vascular
function [37]. Although the effect of the novel milk-drink
on glucose response did not differ from the other studied
drinks, it produced a significantly lower postprandial
insulin concentration. The novel milk drink has the low-
est carbohydrate content, which can partly explain the
lower insulin response. Another potential explanation for
the lower insulin response is the fibre added in the milk
drink. Polydextrose, the soluble fibre used in the present
study, is a polysaccharide, but it has physiologic effects
comparable to other dietary fibres [38]. In several studies,
fibre-rich foods have been shown to lower insulin
responses in healthy and diabetic subjects [39-45]. On the
other hand, Gruendel et al. observed that when 5 or 10 g
of insoluble carob fibre are consumed with a glucose
(A) Changes from fasting values for insulin responses following the ingestion of a fibre-enriched milk drink (black square), fat- free milk (black triangle up) and a fat- and lactose-free milk drink (black triangle down) Figure 1
(A) Changes from fasting values for insulin responses following the ingestion of a fibre-enriched milk drink 
(black square), fat-free milk (black triangle up) and a fat- and lactose-free milk drink (black triangle down). (B) 
Changes from fasting values for glucose responses following the ingestion of a fibre-enriched milk drink (black square), fat-free 
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drink, the insulin response increases compared to drink-
ing only a glucose drink [46]. To our knowledge, the effect
of fibre enrichment in milk on insulin levels has not been
studied before. Because the milk carbohydrate, lactose, is
totally removed from the novel milk drink using the chro-
matographic technique, the energy and monosaccharide
content of the milk drink is further reduced. Therefore, in
addition to the added polydextrose, the low-energy and
low-carbohydrate content of the milk drink have most
likely contributed to the observed effect. Epidemiological
studies have shown high vitamin D status to be inversely
associated with insulin resistance [47]. Regardless of this
interesting finding, it is unlikely that the vitamin D con-
tent of the drink contributed to the lower insulin response
in this study, since all three study drinks contained the
same amount of vitamin D.
The present study does not support the earlier studies
which indicate that fibre and fibre-enriched products sta-
bilise postprandial glucose levels [22,39,40,44,45]. How-
ever, a trend towards a more balanced glucose response
was observed after the consumption of the fibre-enriched
milk drink. Generally, dairy products have a low glycae-
mic response [48], which is due to their low carbohydrate
and high protein content [49]. The fibre enrichment and
the low calorie and carbohydrate content of the milk
drink might explain the shape of the glucose curve. Fur-
thermore, the lack of significant difference in the post-
prandial glucose response could also be due to the
selection of healthy, glucose-tolerant individuals who
show only minor fluctuation in glucose levels due to a
well-preserved insulin secretion capacity.
Dietary fibre may enhance satiety by slowing gastric emp-
tying and by delaying absorption [35]. Soluble fibres
absorb water, form a gel and may increase abdominal dis-
tension, which creates a sensation of fullness [34,50]. We
used a Visual Analogue Scale (VAS) questionnaire to study
the effect of milk products on satiety, because it is the
most commonly used satiety measurement and makes
comparison to other studies possible [51]. Another rating
scale, Satiety Labeled Intensity Magnitude (SLIM) [52],
was also used. In the present study, fibre enrichment did
not increase satiety. Furthermore, neither differences in
the energy intake at the subsequent breakfast meals or in
the energy intake during the rest of the study day were
Table 2: AUC minus baseline for subjective satiety ratings 180 minutes after ingestion of tested products (n = 26).
Satiety rating Study day with P-value*
Fibre-enriched milk drink Fat-free milk Lactose-free milk drink
Mean SD Mean SD Mean SD
Hunger 0.8 20.4 1.0 15.7 3.7 16.1 0.73
Desire to eat 1.0 19.9 1.3 14.8 2.3 13.9 0.94
Fullness 7.4 15.0 5.3 10.8 6.4 14.8 0.79
Prospective food consumption 1.1 15.7 3.3 13.5 4.5 9.8 0.63
SLIM 0.7 12.7 -1.3 10.5 -4.6 9.7 0.14
SLIM, Satiety Labeled Intensity Magnitude for hunger and fullness
*ANOVA for repeated measurements
Table 3: Energy, macronutrient and fibre intake during the three study days (n = 25).
Study day with P-value*
Fibre-enriched milk drink Fat-free milk Lactose-free milk drink
Mean SD Mean SD Mean SD
Energy (kJ) 7767 2572 7041 1732 6707 1985 0.10
Protein (g) 84.2 23.6 83.0 23.2 75.7 22.4 0.25
Carbohydrates (g) 231† 86 197‡ 49 195 68 0.033
Total fat (g) 58.5 29.0 54.8 22.5 49.2 19.6 0.26
SAFA (g) 25.8 14.1 24.8 12.5 22.4 10.1 0.36
PUFA (g) 9.5 6.3 7.1 3.4 7.0 3.2 0.093
MUFA (g) 17.1 9.8 16.1 8.6 15.4 8.3 0.78
Fibre (g) 30.6 21.3 24.8 12.9 26.5 16.4 0.28
SAFA, saturated fatty acids; PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids
*ANOVA for repeated measurements
†,‡Mean values within a row with unlike superscript letters are significantly different (P < 0.05).Nutrition Journal 2009, 8:45 http://www.nutritionj.com/content/8/1/45
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found. The reason for not finding a satiating effect in this
study might be due to the moderate amount of fibre in the
study product and the fairly small amount of product con-
sumed. In a study by King et al. [53], the effects of poly-
dextrose and xylitol on appetite were examined
independently and together with a greater amount of fibre
than in this study. King et al. used 25 g of polydextrose or
25 g of xylitol or 12.5 g of polydextrose and 12.5 g of xyl-
itol. In the present study, the amount of polydextrose was
only 3 g. In the study by King et al., the combination of the
studied carbohydrates significantly increased the feeling
of fullness. Used alone, polydextrose significantly sup-
pressed food intake compared to a control product. Simi-
larly, another soluble fibre (oligofructose, 16 g/day)
significantly reduced energy intake, hunger and prospec-
tive food consumption and increased satiety compared to
placebo treatment [54]. The products studied in the
present study were beverages, which may have different
effects on satiety compared to solid foods [55].
Conclusion
A fibre-enriched fat-free milk drink with a low carbohy-
drate content helped to balance the postprandial insulin
response. The insulin lowering effect of the fibre-enriched
milk drink warrants further investigation in people suffer-
ing from impaired glucose regulation. More research is
also needed to establish whether the changes in insulin
response occur when the milk-drink is consumed with a
whole meal and also to investigate the long term effects of
fibre-enriched dairy products on glucose and insulin
metabolism.
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